NEWS RELEASE Data to be Presented at the Annual ASCO Genitourinary Cancers Symposium Data to further support clinical adoption of SelectMDx and ConfirmMDx IRVINE, CA, and HERSTAL, BELGIUM - February 15, 2019 - MDxHealth SA (Euronext: MDXH.BR) today announced that positive data and observations from multiple studies and patient registries demonstrating the value of SelectMDx and ConfirmMDx for Prostate Cancer diagnosis, will be presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place in San Francisco, California, February 14-16, 2019. The data, to be presented in four separate poster presentations, highlights: Annual cost savings of nearly...
|